HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Vittorio Ruggero Zilioli Selected Research
Vittorio Ruggero Zilioli Research Topics
Disease
10
Hodgkin Disease (Hodgkin's Disease)
05/2024 - 01/2009
7
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2023 - 05/2018
3
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2023 - 01/2023
2
Neoplasms (Cancer)
08/2023 - 01/2018
2
Infections
02/2022 - 05/2018
2
Lymphoma (Lymphomas)
05/2018 - 06/2011
1
Disease Progression
01/2023
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2023
1
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2023
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2022
1
Hematologic Neoplasms (Hematological Malignancy)
02/2022
1
Graft vs Host Disease (Graft-Versus-Host Disease)
12/2021
1
Thrombocytopenia (Thrombopenia)
05/2018
1
Diarrhea
05/2018
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2018
1
T-Cell Lymphoma (Lymphoma, T Cell)
01/2018
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2015
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2005
Drug/Important Bio-Agent (IBA)
3
Agammaglobulinaemia Tyrosine Kinase
IBA
10/2023 - 12/2021
2
Anthracyclines
IBA
10/2023 - 01/2015
2
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2023 - 11/2021
2
Rituximab (Mabthera)
FDA Link
01/2023 - 02/2022
2
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
07/2021 - 12/2020
1
brexucabtagene autoleucel
IBA
10/2023
1
parsaclisib
IBA
08/2023
1
Hemoglobins (Hemoglobin)
IBA
02/2023
1
romidepsin (FK228)
FDA Link
01/2023
1
liposomal doxorubicin (Doxil)
FDA Link
01/2023
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2023
1
Prednisone (Sone)
FDA Link
Generic
01/2023
1
Vincristine (Oncovin)
FDA Link
Generic
01/2023
1
Lamivudine (Epivir)
FDA Link
02/2022
1
Hepatitis B Core Antigens
IBA
02/2022
1
Hepatitis B Surface Antigens (HBsAg)
FDA Link
02/2022
1
Surface Antigens (Surface Antigen)
IBA
02/2022
1
lipoarabinomannan (LAM)
IBA
02/2022
1
Anti-Idiotypic Antibodies
IBA
02/2022
1
Antiviral Agents (Antivirals)
IBA
02/2022
1
Brentuximab Vedotin
IBA
02/2022
1
Chimeric Antigen Receptors
IBA
12/2021
1
Vinblastine (Vinblastine Sulfate)
FDA Link
11/2021
1
Dacarbazine (DIC)
FDA Link
Generic
11/2021
1
Bleomycin (Blenoxane)
FDA Link
Generic
11/2021
1
ibrutinib
IBA
05/2018
1
Bortezomib (Velcade)
FDA Link
10/2016
1
Gemcitabine
FDA Link
01/2016
1
Vinorelbine (Navelbine)
FDA Link
Generic
01/2016
1
Bendamustine Hydrochloride
FDA Link
01/2016
1
Alkylating Agents
IBA
01/2015
1
Nucleosides
IBA
01/2015
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
06/2011
1
plerixafor
FDA Link
06/2011
1
Cytarabine (Cytosar-U)
FDA Link
Generic
09/2005
Therapy/Procedure
8
Stem Cell Transplantation
01/2023 - 01/2016
7
Drug Therapy (Chemotherapy)
05/2024 - 06/2011
6
Therapeutics
05/2024 - 01/2016
2
Salvage Therapy
02/2022 - 01/2015
2
Induction Chemotherapy
01/2020 - 01/2016
1
Radiotherapy
11/2021
1
Immunotherapy
05/2018
1
Radiofrequency Ablation
01/2009
1
Autologous Transplantation
09/2005
1
Hematopoietic Stem Cell Transplantation
09/2005